CSL Ltd. | Key People and Executives
Paul Roger Perreault
Chief Executive Officer, Executive Director & MD
Brian Anthony McNamee
Independent Non-Executive Director
Tachi Yamada
Independent Non-Executive Director
Shah Abbas Hussain
Independent Non-Executive Director
Megan Clark
Independent Non-Executive Director
Marie McDonald
Independent Non-Executive Director
Bruce Robert Brook
Independent Non-Executive Director
Christine E. O’Reilly
Independent Non-Executive Director
David Westbrook Anstice
Independent Non-Executive Director
Paul Roger Perreault
Chief Executive Officer, Executive Director & MD
David Mark Lamont
Chief Financial Officer
Charmaine Gittleson
Chief Medical Officer
Andrew Cuthbertson
Chief Scientific Officer
Bill Campbell
Chief Commercial Officer & Executive VP
Andrew Nash
Senior Vice President-Research
Christina Hickie
Senior Manager-Communications
Bernard Ronchi
Senior Manager-Investor Relations
Mark Dehring
Head-Investor Relations
Elizabeth Walker
Chief Human Resources Officer & Executive VP
Fiona McCallum Mead
Secretary & Head-Group Governance
Gregory Boss
Executive VP-Legal & Group General Counsel
Brian Anthony McNamee
Independent Non-Executive Director
Tachi Yamada
Independent Non-Executive Director
Shah Abbas Hussain
Independent Non-Executive Director
Megan Clark
Independent Non-Executive Director
Marie McDonald
Independent Non-Executive Director
Bruce Robert Brook
Independent Non-Executive Director
Christine E. O'Reilly
Independent Non-Executive Director
David Westbrook Anstice
Independent Non-Executive Director
| Address |
45 Poplar Road
Parkville Victoria (VIC) 3052
Australia
|
|
Employees
|
- |
| Website |
http://www.csl.com.au |
| Updated |
07/08/2019 |
| CSL Ltd. is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. |
